HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Clark Capital Management Group, Inc.'s Holding History (CIK: 0001352187)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 143,886 Value ($000) $9,684 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 202,965 Value ($000) $14,885 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 177,383 Value ($000) $9,227 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 205,762 Value ($000) $13,130 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 178,827 Value ($000) $8,550 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 137,172 Value ($000) $7,852 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 102,925 Value ($000) $5,389 Avg Close $43.86 Range $37.73 - $53.00
Q1 2023
Shares 29,636 Value ($000) $1,132 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 34,623 Value ($000) $1,970 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 33,604 Value ($000) $1,329 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 33,766 Value ($000) $1,486 Avg Close $43.25 Range $36.95 - $48.58
Q4 2021
Shares 55,222 Value ($000) $2,220 Avg Close $37.33 Range $31.79 - $41.20
Q3 2021
Shares 57,873 Value ($000) $2,354 Avg Close $41.81 Range $37.80 - $46.62